HSP90AA1 and cancer: Plasma HSP90α is overexpress and increases multi-malignant phenotypes including chemoresistance to cisplatin as well as metastatic potentials in various types of cancers (Eustace et al., 2004; Chang et al., 2009; Zuehlke et al., 2015).